Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Medicine. What are the right targets for psychopharmacology?

× No keyword cloud information.

75 in total

Review 1. NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.

Authors: John H Krystal; D Cyril D'Souza; Daniel Mathalon; Edward Perry; Aysenil Belger; Ralph Hoffman
Journal: Psychopharmacology (Berl) Date: 2003-09-02 Impact factor: 4.530

2. Cognition in schizophrenia: from basic science to clinical treatment.

Authors: Philip D Harvey; Mark A Geyer; Trevor W Robbins; John H Krystal
Journal: Psychopharmacology (Berl) Date: 2003-08-30 Impact factor: 4.530

3. Breaking the log-jam in treatment development for cognition in schizophrenia: NIMH perspective.

Authors: Wayne S Fenton; Ellen L Stover; Thomas R Insel
Journal: Psychopharmacology (Berl) Date: 2003-09-02 Impact factor: 4.530

Review 4. Translational Assessment of Reward and Motivational Deficits in Psychiatric Disorders.

Authors: Andre Der-Avakian; Samuel A Barnes; Athina Markou; Diego A Pizzagalli
Journal: Curr Top Behav Neurosci Date: 2016

5. Social Disconnection in Schizophrenia and the General Community.

Authors: Michael F Green; William P Horan; Junghee Lee; Amanda McCleery; L Felice Reddy; Jonathan K Wynn
Journal: Schizophr Bull Date: 2018-02-15 Impact factor: 9.306

6. Regulation of synaptic plasticity in a schizophrenia model.

Authors: Barbara Gisabella; Vadim Y Bolshakov; Francine M Benes
Journal: Proc Natl Acad Sci U S A Date: 2005-08-30 Impact factor: 11.205

7. Bug-eyed and breathless: emerging crises involving values.

Authors: John Z Sadler
Journal: World Psychiatry Date: 2005-06 Impact factor: 49.548

Review 8. Psychopharmacology and memory.

Authors: W Glannon
Journal: J Med Ethics Date: 2006-02 Impact factor: 2.903

Review 9. Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia.

Authors: David A Lewis; Takanori Hashimoto; Harvey M Morris
Journal: Neurotox Res Date: 2008-10 Impact factor: 3.911

10. Should cognitive impairment be included in the diagnostic criteria for schizophrenia?

Authors: Richard S E Keefe
Journal: World Psychiatry Date: 2008-02 Impact factor: 49.548